GlassScriptPhysician profile
Andrew L Kominsky
NPI 1265478697
$13,034.98
in general payments reported to CMS, 2019-2025
73 companies · $4,008 in 2025
The $4,008 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.99 · 2022: $1,360 · 2023: $3,023 · 2024: $4,629 · 2025: $4,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,430 · Long Term Medical Supply Or Device Loan: $2,164 · Education: $65.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,429.87 |
| Long Term Medical Supply Or Device Loan | $2,163.62 |
| Education | $65.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,222.29 | 2022-2025 | Kisqali |
| Janssen Biotech, INC. | $846.10 | 2022-2025 | Erleada, Darzalex, Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $819.01 | 2022-2025 | Opdivo, Reblozyl, Opdualag |
| Pfizer INC. | $804.97 | 2020-2025 | |
| Genentech USA, INC. | $512.15 | 2022-2025 | Tecentriq, Alecensa, Rozlytrek |
| Astrazeneca Pharmaceuticals LP | $488.97 | 2022-2025 | Enhertu, Imfinzi, Calquence |
| Eisai INC. | $459.37 | 2022-2025 | |
| Celgene Corporation | $444.24 | 2022-2025 | Reblozyl, Opdualag |
| Merck Sharp & Dohme LLC | $442.92 | 2022-2025 | Keytruda, Lynparza, Reblozyl |
| Incyte Corporation | $283.12 | 2022-2025 | Monjuvi, Jakafi, Niktimvo |
| Lilly USA, LLC | $276.45 | 2022-2025 | Verzenio |
| Abbvie INC. | $245.57 | 2024-2025 | |
| Astellas Pharma US INC | $237.39 | 2023-2025 | Cresemba, Vyloy, Padcev |
| Takeda Pharmaceuticals U.S.A., INC. | $229.47 | 2022-2025 | Ninlaro, Iclusig, Vpriv |
| Genzyme Corporation | $208.43 | 2022-2025 |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $202.49 | 2022-2025 | Ojjaara, Jemperli, Zejula |
| Array Biopharma INC | $191.94 | 2023-2025 | Mektovi, Braftovi, Lorbrena |
| Regeneron Healthcare Solutions, INC. | $190.64 | 2023-2025 | Libtayo |
| Emd Serono, INC. | $176.51 | 2023-2025 | Bavencio |
| Beigene USA, INC. | $138.42 | 2023-2025 | Brukinsa |
| Pharmacyclics LLC, An Abbvie Company | $136.66 | 2022-2023 | Imbruvica, Epkinly |
| Exelixis INC. | $136.24 | 2022-2025 | Cabometyx |
| Seagen INC. | $134.93 | 2022-2023 | Tukysa, Adcetris, Padcev |
| Tempus Ai, INC | $131.45 | 2024-2025 | Xt Cdx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.98 | 2022-2024 | Gilotrif |
| Bayer Healthcare Pharmaceuticals INC. | $115.63 | 2022-2025 | |
| Amgen INC. | $109.30 | 2022-2023 | Kyprolis, Blincyto, Nplate |
| Progenics Pharmaceuticals, INC. | $96.77 | 2023-2025 | Pylarify |
| Beone Medicines USA, INC. | $95.84 | 2025 | Tevimbra, Brukinsa |
| Pharmacosmos Therapeutics INC. | $93.52 | 2022-2024 | Monoferric |
| Jazz Pharmaceuticals INC. | $77.79 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $65.65 | 2025 | Onivyde |
| Intuitive Surgical, INC. | $65.00 | 2025 | |
| Morphosys, US INC. | $61.65 | 2023 | Monjuvi |
| Daiichi Sankyo INC. | $57.74 | 2023-2025 | Enhertu, Vanflyta |
| Adaptive Biotechnologies Corporation | $57.05 | 2025 | Clonoseq |
| Macrogenics, INC. | $52.65 | 2022-2023 | |
| Puma Biotechnology, INC. | $50.51 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $49.50 | 2023-2024 | Myrisk, Precisetumor |
| Accord Healthcare, INC. | $46.93 | 2024 | |
| Springworks Therapeutics, INC. | $46.76 | 2024 | Ogsiveo |
| Spectrum Pharmaceuticals INC. | $45.07 | 2024-2025 | Rolvedon |
| Sumitomo Pharma America, INC. | $44.02 | 2024-2025 | Gemtesa, Orgovyx |
| Mirati Therapeutics, INC. | $43.86 | 2023-2024 | Krazati |
| Karyopharm Therapeutics INC. | $42.72 | 2025 | Xpovio |
| Aveo Pharmaceuticals, INC. | $41.74 | 2024-2025 | |
| Sobi, INC | $41.45 | 2024 | |
| Servier Pharmaceuticals LLC | $39.66 | 2022 | |
| Alnylam Pharmaceuticals INC. | $33.98 | 2022-2024 | Oxlumo |
| Fresenius Kabi USA, LLC | $33.21 | 2024 | Stimufend, Idacio |
| Stryker Corporation | $30.80 | 2023 | Spy-Phi System |
| Cti Biopharma Corp. | $27.79 | 2023 | Vonjo |
| Verity Pharmaceuticals INC. | $25.94 | 2024 | Trelstar |
| Iovance Biotherapeutics, INC. | $24.75 | 2025 | Amtagvi |
| Dendreon Pharmaceuticals LLC | $23.04 | 2025 | Provenge |
| G1 Therapeutics, INC. | $22.89 | 2022 | |
| Taiho Oncology, INC. | $22.56 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.00 | 2024 | Rybrevant |
| Kyowa Kirin, INC. | $21.65 | 2024 | Crysvita |
| Telix Pharmaceuticals | $19.94 | 2023 | Illuccix |
| Acrotech Biopharma INC. | $19.58 | 2025 | Beleodaq |
| Geron Corporation | $19.24 | 2025 | Rytelo |
| Blueprint Medicines Corporation | $18.07 | 2023 | Ayvakit |
| Agios Pharmaceuticals, INC. | $17.50 | 2022 | |
| Rigel Pharmaceuticals, INC. | $16.47 | 2024 | Rezlidhia, Tavalisse |
| Alexion Pharmaceuticals, INC. | $16.43 | 2022 | |
| Eusa Pharma (US) LLC | $16.35 | 2022 | |
| Pharming Healthcare, INC. | $16.20 | 2024 | Ruconest |
| Tersera Therapeutics LLC | $16.10 | 2023 | Xermelo |
| Kite Pharma, INC. | $14.65 | 2023 | |
| Adc Therapeutics America, INC. | $13.73 | 2024 | |
| Helsinn Therapeutics (U.S.), INC. | $13.21 | 2024 | Akynzeo |
| Pharmaand Gmbh | $6.38 | 2025 | Rubraca |
Drugs and devices associated with these payments
Kisqali $2,499Reblozyl $444Erleada $417Lenvima $385Keytruda $377Scemblix $369Tecentriq $352Opdivo $348Imbruvica $318Alecensa $252Darzalex $240Verzenio $209Tecvayli $204Padcev $200Braftovi $192Mektovi $192Libtayo $191Enhertu $190Monjuvi $186Xtandi $184Epkinly $171Adcetris $167Ibrance $166Brukinsa $165Tukysa $160Talzenna $158Elrexfio $157Imfinzi $149Lorbrena $129Ninlaro $128Jakafi $121Ojjaara $117Rozlytrek $114Cabometyx $114Cresemba $111Inlyta $110Fabhalta $109Orgovyx $108Polivy $108Opdualag $106Sarclisa $106Talvey $104Gilotrif $98.92Pylarify $96.77Vyloy $88.42Xalkori $88.08Niktimvo $85.33Paxlovid $80.81Bosulif $80.79Venclexta $78.04Zepzelca $77.79Lynparza $76.62Bavencio $69.60Vonjo $69.24Tevimbra $69.18Promacta $68.56Onivyde $65.65Da Vinci Surgical System $65.00Monoferric $59.79Xt Cdx $57.89Perjeta $57.31Clonoseq $57.05Lutathera $53.61Nubeqa $52.93Balversa $50.27Akeega $50.27Stivarga $48.86Piqray $47.92Camcevi $46.93Ogsiveo $46.76Rybrevant $46.56Rolvedon $45.07Gazyva $45.06Krazati $43.86Xpovio $42.72Fotivda $41.74Itovebi $40.51Illuccix $39.88Xofigo $36.82Comirnaty $36.42Phesgo $35.60Besponsa $35.04Tecentriq Hybreza $34.43Iclusig $33.46Zejula $33.32Jemperli $33.32Vitrakvi $32.75Kyprolis $32.41Blincyto $32.41Myrisk $30.86Spy-Phi System $30.80Oxbryta $29.34Gemtesa $29.06Elahere $27.50Margenza $27.34Vanflyta $26.48Trelstar $25.94Vpriv $25.77Amtagvi $24.75Sprycel $23.87
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kominsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.